Clinical Trials Browser

Anemia, Hematologic Diseases, Hemoglobinuria, Paroxysmal, Hypersplenism, Leukopenia, Myeloproliferative Disorders, Thrombocytopenia, Antiphospholipid Syndrome, Thrombophilia

NCT06153394 2024-04-23

PRIORITY

Phase 3 Not yet recruiting

50 enrolled

Digestive System Diseases, Thrombosis, Thrombophilia

NCT02622815 2018-10-29

HYPERCAN

Unknown

16,000 enrolled

Thrombosis, Thrombophilia

NCT01372553 2014-04-16

GGMI

Completed

1,184 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Colonic Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Thrombophilia

NCT00210197 2013-07-26

EHC

Completed

48 enrolled

Breast

Blood Coagulation Disorders, Breast Neoplasms, Thrombophilia

NCT00192829 2007-04-11

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Unknown

100 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thrombosis, Thrombophilia, Venous Thromboembolism

NCT00400504 2006-11-17

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Unknown

500 enrolled

Neoplasms, Thromboembolism, Thrombophilia

Clinical Trials

EHPVO-HEM

PRIORITY

HYPERCAN

GGMI

EHC

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)